792 followers
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma ... https://t.co/b5IXfc5oSS
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma ... https://t.co/b5IXfc5oSS
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma https://t.co/b5IXfbNNui
Using in vitro experiments, investigators at @FudanUniv Liver Cancer Institute found that #anlotinib had significant effects on proliferation inhibition, migration, and cell-cycle arrest in intrahepatic #cholangiocarcinoma. 📔@cddpress: https://t.co/VsMIE3